← Open Payments lookup

HENRY EMERLE: Open Payments

NPI 1336450790 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,197 in 24 payments from 9 companies in 2025. Trend: 2023 $51 · 2024 $562 · 2025 $2,197

Consulting: $1,840Food & beverage: $357
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$1,948
Otsuka America Pharmaceutical, Inc.3$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$50
Teva Pharmaceuticals USA, Inc.2$40
ABBVIE INC.1$28
Axsome Therapeutics, Inc.1$19
Lundbeck LLC1$19
Almatica Pharma LLC1$18
Corium, LLC1$9

Products named: COBENFY, CAPLYTA, UZEDY, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, Auvelity.

Industry payments across IA — which companies pay providers there.